ViewRay Inc (OTCPK:VRAYQ)
$ 0.00001 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

ViewRay Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 12:00PM GMT
Release Date Price: $3.45 (-3.09%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Great. Good morning. Thank you for joining us for the second day at the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, a medical device analyst here at Morgan Stanley. It's my pleasure to have VRAY with me today, CEO, Scott Jake, CFO, Zach Stassen. Thank you both for being here. Really quickly disclosure see morganstanley.com/disclosures.

Questions & Answers

Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

With that, thank you, and I'd love to get started with what we saw recently, China approval. And I know it's early, and we've talked a lot recently in China in terms of COVID lock down and all of the dynamics there. But just high level, would love to get your thoughts now with this approval in hand, what are you able to do that you weren't with your partner before? How do you move this process forward and what is the outlook?

Scott William Drake
ViewRay, Inc. - President, CEO & Director

Yes.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot